fluorexon has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blom, AM; Felberg, A; Kowalska, D; Lundin, J; Ma, S; Okrój, M; Österborg, A; Stasiłojć, G; Urban, A | 1 |
1 trial(s) available for fluorexon and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies.
Topics: Aged; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cohort Studies; Complement System Proteins; Cytotoxicity, Immunologic; Female; Fluoresceins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Monitoring, Immunologic; Sheep | 2020 |